Published in Clin Infect Dis on March 01, 1999
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis (2009) 3.12
Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults. Clin Infect Dis (2010) 1.52
Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults. Vaccine (2011) 1.04
Enhanced cellular immunity in macaques following a novel peptide immunotherapy. J Virol (2005) 1.02
Efficacy and clinical effectiveness of influenza vaccines in HIV-infected individuals: a meta-analysis. BMC Infect Dis (2006) 1.01
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One (2011) 1.00
Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants. J Infect Dis (2015) 0.85
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. Hum Vaccin Immunother (2012) 0.84
Influenza, influenza virus vaccine, and human immunodeficiency virus infection. Clin Infect Dis (1999) 0.82
Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS One (2015) 0.81
T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines. AIDS Res Hum Retroviruses (2010) 0.80
Key differences in B cell activation patterns and immune correlates among treated HIV-infected patients versus healthy controls following influenza vaccination. Vaccine (2015) 0.77
Influenza vaccination in HIV-positive subjects: latest evidence and future perspective. J Prev Med Hyg (2013) 0.75
Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore. Hum Vaccin Immunother (2017) 0.75
Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand. Clin Infect Dis (2015) 0.75
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science (1998) 19.40
The cost effectiveness of combination antiretroviral therapy for HIV disease. N Engl J Med (2001) 5.89
Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J Virol (1998) 5.48
Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A (2000) 5.36
Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis (2001) 4.94
Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients. Am J Med (1980) 4.45
Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology (1999) 3.16
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients. Am J Med (1980) 3.03
Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med (1989) 2.77
The cost-effectiveness of preventing AIDS-related opportunistic infections. JAMA (1998) 2.69
HLA and mate choice in humans. Am J Hum Genet (1997) 2.66
Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med (1987) 2.64
Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med (1981) 2.56
Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. J Clin Microbiol (1978) 2.44
Molecular changes associated with the transmission of avian influenza a H5N1 and H9N2 viruses to humans. J Med Virol (2002) 2.35
Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: a cross-sectional study in a municipal hospital clinic. Am J Med (1992) 2.25
Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial. J Infect Dis (1995) 2.23
How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS) Rheumatology (Oxford) (2000) 2.21
Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med (1988) 2.17
Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. J Gen Virol (2001) 2.15
Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis (2002) 2.11
Outcome in patients who require a gastrostomy after stroke. Age Ageing (1995) 2.11
Adherence of isolates of Neisseria meningitidis from patients and carriers to human buccal epithelial cells. J Infect Dis (1980) 2.05
Factitious HIV infection: the importance of documenting infection. Ann Intern Med (1994) 2.05
Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med (1987) 2.04
Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis (1986) 2.04
Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort. J Gen Intern Med (1997) 2.00
Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet (1986) 1.96
Nutritional outcome and pneumonia in critical care patients randomized to gastric versus jejunal tube feedings. The Critical Care Research Team. Crit Care Med (1992) 1.81
Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.78
Rapid serogroup identification of Neisseria meningitidis by using antiserum agar: Prevalence of serotypes in a disease-free military population. J Clin Microbiol (1979) 1.71
Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia. J Infect Dis (1993) 1.69
Subcellular localization, stoichiometry, and protein levels of 26 S proteasome subunits in yeast. J Biol Chem (1999) 1.69
Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine. Lancet (1989) 1.61
Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med (1987) 1.59
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med (1988) 1.58
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med (1984) 1.52
Choice and availability of takeaway and restaurant food is not related to the prevalence of adult obesity in rural communities in Australia. Int J Obes (Lond) (2005) 1.42
Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model. Infect Immun (1979) 1.41
Clients' interpretation of risks provided in genetic counseling. Am J Hum Genet (1986) 1.39
MF59. Design and evaluation of a safe and potent adjuvant for human vaccines. Pharm Biotechnol (1995) 1.37
Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry (2002) 1.36
Epidemiology of nosocomial pneumonia. New perspectives on an old disease. Chest (1995) 1.36
Pseudobacteremia traced to cross-contamination by an automated blood culture analyzer. Infect Control (1984) 1.33
Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol (2009) 1.33
Preparing for pandemic influenza: the need for enhanced surveillance. Emerg Infect Dis (1999) 1.32
Importance sampling. I. Computing multimodel p values in linkage analysis. Am J Hum Genet (1992) 1.31
HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors. J Gen Intern Med (1998) 1.30
Surveillance and impact of influenza in the United States. Vaccine (1999) 1.29
Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs. J Infect Dis (2001) 1.29
Provider attitudes regarding participation of women and persons of color in AIDS clinical trials. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.29
Nonresponsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med (1986) 1.29
Sequential imputation and multipoint linkage analysis. Genet Epidemiol (1993) 1.28
A large outbreak of infections caused by a strain of Staphylococcus aureus resistant of oxacillin and aminoglycosides. Am J Med (1981) 1.28
A model clinic for the initial evaluation and establishment of primary care for persons infected with human immunodeficiency virus. Arch Intern Med (1995) 1.27
Genetics of stuttering: a critical review. J Speech Hear Res (1996) 1.27
Amantadine-resistant influenza A in nursing homes. Identification of a resistant virus prior to drug use. Arch Intern Med (1995) 1.25
Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s. Am J Med (1991) 1.24
Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. J Infect Dis (1983) 1.24
M proteins of group G streptococci isolated from bacteremic human infections. Infect Immun (1987) 1.24
Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol). Cancer Res (1996) 1.23
Immunohistochemical and in situ hybridization studies of influenza A virus infection in human lungs. Am J Clin Pathol (2000) 1.22
Nosocomial dermatitis and pruritus caused by pigeon mite infestation. Arch Intern Med (1987) 1.21
Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. J Infect Dis (1987) 1.19
Cruise ships: high-risk passengers and the global spread of new influenza viruses. Clin Infect Dis (2000) 1.19
Relation between HIV-1 and hepatitis C viral load in patients with hemophilia. J Acquir Immune Defic Syndr (2001) 1.16
Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial. Ann Intern Med (1990) 1.15
Survey of AIDS knowledge and behavior changes among Massachusetts adults. Prev Med (1989) 1.15
KCNMB1 regulates surface expression of a voltage and Ca2+-activated K+ channel via endocytic trafficking signals. Neuroscience (2006) 1.14
Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols. Am J Med (1984) 1.14
Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners. J Infect Dis (1998) 1.13
Risk factors for nosocomial pneumonia. Focus on prophylaxis. Med Clin North Am (2001) 1.12
Serogroup identification of meningococci by a modified antiserum agar method. J Clin Microbiol (1979) 1.12
Nosocomial pneumonia in the 1990s: update of epidemiology and risk factors. Semin Respir Infect (1990) 1.12
Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996. Semin Respir Infect (1996) 1.11
Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes. Infect Immun (1982) 1.10
Influenza. Infect Dis Clin North Am (2000) 1.10
Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs (2001) 1.10
Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. J Infect Dis (1999) 1.09
Knowledge and attitudes of AIDS health care providers before and after education programs. Public Health Rep (1987) 1.09
Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria. J Infect Dis (1977) 1.07
Polymorphisms of GLUT2 and GLUT4 genes. Use in evaluation of genetic susceptibility to NIDDM in blacks. Diabetes (1990) 1.07
Genome-wide screen for atopy susceptibility alleles in the Hutterites. Clin Exp Allergy (1999) 1.07
Occupational hazards to hospital personnel. Ann Intern Med (1985) 1.07
Knowledge about HIV and behavioral risks of foreign-born Boston public school students. Am J Public Health (1991) 1.07
A multivariate analysis of risk factors for hepatitis B virus infection among hospital employees screened for vaccination. Am J Epidemiol (1984) 1.06
Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature. Medicine (Baltimore) (1990) 1.05
Endocytic trafficking signals in KCNMB2 regulate surface expression of a large conductance voltage and Ca(2+)-activated K+ channel. Neuroscience (2007) 1.04
Genetic aspects of early childhood stuttering. J Speech Hear Res (1993) 1.04
The Boston AIDS Survival Score (BASS): a multidimensional AIDS severity instrument. Am J Public Health (1997) 1.00
Comparative study of intra-articular pressure dynamics in joints with acute traumatic and chronic inflammatory effusions: potential implications for hypoxic-reperfusion injury. Ann Rheum Dis (1991) 1.00
Use of paper-absorbed fingerstick blood samples for studies of antibody to human immunodeficiency virus type 1 in intravenous drug users. J Infect Dis (1990) 1.00
Diagnosis of murine mycoplasmal infections by enzyme-linked immunosorbent assay (ELISA). Isr J Med Sci (1987) 0.99
A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection. Med Decis Making (1998) 0.99
Impact of epidemic influenza A-like acute respiratory illness in a remote jungle highland population in Irian Jaya, Indonesia. Clin Infect Dis (1998) 0.98
Identification of the minor guanylated tRNA of rabbit reticulocytes. Nucleic Acids Res (1976) 0.98